project id: TCGA-BLCA; case submitter id: TCGA-DK-AA74; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.43; rna integrity number: 7.0; age at index: 75; days to birth: -27730; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1935; age at diagnosis: 27730; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1708.0; icd 10 code: C67.1; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Dome of bladder; synchronous malignancy: Not Reported; tissue or organ of origin: Dome of bladder; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.8630136986301369; pack years smoked: 34.0; is ffpe: false; composition: Not Reported; days to collection: 1258; initial weight: 620.0; sample id: 3c6f20b8-63a3-4992-a53f-c56d76153c5b; sample submitter id: TCGA-DK-AA74-01A; portion id: 6b925d9a-6c66-4446-a1f4-3a904a65180b; portion submitter id: TCGA-DK-AA74-01A-11; slide id: 9d351ec2-451a-42d1-9e5a-dbd54efb56ab; slide submitter id: TCGA-DK-AA74-01A-01-TSA; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 7.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; section location: TOP;